Literature DB >> 1293870

Neuroprotective role of adenosine in cerebral ischaemia.

K A Rudolphi1, P Schubert, F E Parkinson, B B Fredholm.   

Abstract

Several lines of evidence suggest that adenosine may be an endogenous protective agent in cerebral ischaemia. Adenosine is normally present in the extracellular fluid in most tissues of the body, including the brain, and its level increases dramatically following hypoxia or ischaemia. The rate of adenosine production is enhanced when the energy demand is larger than the rate of energy supply. Adenosine acts on specific receptors that are present in most cells in the body and that produce cellular effects that tend to antagonize a number of pathological events thought to be instrumental for ischaemic nerve cell death. Karl Rudolphi and colleagues review evidence for the neuroprotective potential of adenosine and indicate some targets for drug development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293870     DOI: 10.1016/0165-6147(92)90141-r

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  68 in total

1.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation.

Authors:  A M Sebastião; A de Mendonca; T Moreira; J A Ribeiro
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

3.  Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina.

Authors:  Claudio Macaluso; Laura J Frishman; Beatrice Frueh; Alain Kaelin-Lang; Shoken Onoe; Günter Niemeyer
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

4.  Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase.

Authors:  John W Daly; Dan Shi; William L Padgett; Xiao-Duo Ji; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1997-10-01       Impact factor: 4.360

5.  Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.

Authors:  K Plaschke; M Grant; M A Weigand; J Züchner; E Martin; H J Bardenheuer
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

6.  Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones.

Authors:  Nobuyuki Miyazaki; Terumasa Nakatsuka; Daisuke Takeda; Kazuhiro Nohda; Kazuhide Inoue; Munehito Yoshida
Journal:  Pflugers Arch       Date:  2008-06-27       Impact factor: 3.657

7.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

8.  Role of endogenous adenosine in vasovagal syncope.

Authors:  M Sinkovec; A Grad; P Rakovec
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

9.  Species comparison of adenosine receptor subtypes in brain and testis.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Laura Fabbrini; Lara Schmid; Maura Castagna; Laura Giusti; Giovanni Mascia; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-07       Impact factor: 3.996

Review 10.  The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema.

Authors:  Peter Nissen Bjerring; Martin Eefsen; Bent Adel Hansen; Fin Stolze Larsen
Journal:  Metab Brain Dis       Date:  2008-12-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.